// App-Quantinova.ai

4387 : Major Bleeding Complications Among Patients Treated with Ibrutinib and Concomitant Antiplatelet, Anticoagulant, or Supplemental Therapy

Researchers

Presenter

  • Aaron Pavlik

Principal Investigators

  • Hallie Barr

  • Emily Dotson

  • John C. Byrd

  • Kristie A. Blum

  • Farrukh T. Awan

  • Jennifer A. Woyach

  • Kami J. Maddocks

  • Beth A Christian

  • Jeffrey Jones

Medical Centers

  • Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Department of Pharmacy, The Ohio State Wexner Medical Center, Columbus, OH

  • Division of Human Genetics, The Ohio State University, Columbus, OH

  • Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Ibrutinib

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved